PNIBLOG

At the Pacific Brain Health Center in Santa Monica, our experts treat a wide range of neurocognitive conditions that affect the brain such as dementia and Alzheimer’s disease. As these are not curable at this time, clinical trials and research are necessary to develop new and more effective ways of halting and even reversing cognitive decline in these diseases. Find out more in this informative video.

ct-DNA

A recently published paper by Pacific Neuroscience Institute researchers suggests a promising new approach for a biopsy-free method to identify primary brain tumor genetics for personalized treatment options.

Clinical Trials At Pacific Neuroscience Institute Banner

The Clinical Trials Team at Pacific Neuroscience Institute is pleased to announce a new clinical trial this month for post-stroke shoulder pain. Find out about this and more neurological trails.

Stem cell therapy and brain health

Clinical trials using stem cells have shown promising early results as cellular therapies in regenerative medicine, as well as in potential anti-cancer applications. Read more about Dr. Achal Singh Achrol’s neurosurgery clinical trials program and this leading-edge technology.

Glioblastoma MDNA55 Trial Medicenna

Pacific Neuroscience Institute, the leading enrollment site for the MDNA55 clinical trial for Glioblastoma, is still open and enrolling eligible patients. This innovative phase 2 study is for the minimally invasive convection-enhanced delivery (CED) of a new bioengineered targeted therapeutic, MDNA55, in adults with recurrent or progressive glioblastoma. Read more.

Clinical Trials at Pacific Neuroscience Institute

Pacific Neuroscience Institute opens up two new clinical trials this month, one in Essential Tremor and one in Glioblastoma. Find out more about these new trials as well as the other available open neurological studies.